September 2016


CNY research startup raises $3.2 million to develop treatment for vision loss

By Elizabeth Doran |  LAFAYETTE, NY Inside a laboratory tucked in the LaFayette hills south of Syracuse, a small biotech company is quietly developing drugs that may show promise to treat, prevent and possibly even reverse macular degeneration, a disease that’s a leading cause of vision loss. The new drug therapies being developed and tested are designed to work on

Read more